TABLE 2.
Biological process | Count | P | Fold enrichment |
---|---|---|---|
Cell-cell adhesion | 19 | 1.37E−05 | 3.39 |
G1/S transition of mitotic cell cycle | 10 | 7.89E−05 | 5.47 |
Negative regulation of apoptotic process | 34 | 1.78E−04 | 2.02 |
Osteoblast differentiation | 12 | 6.32E−04 | 3.51 |
Negative regulation of cell proliferation | 24 | 1.24E−03 | 2.1 |
Cell adhesion | 28 | 1.25E−03 | 1.96 |
Adrenal gland development | 6 | 1.44E−03 | 7.01 |
Regulation of cell cycle | 11 | 1.99E−03 | 3.27 |
Positive regulation of apoptotic process | 21 | 2.50E−03 | 2.11 |
Angiogenesis | 15 | 1.24E−02 | 2.11 |
Male gonad development | 9 | 1.69E−02 | 2.75 |
Kidney development | 10 | 1.85E−02 | 2.51 |
Blood vessel morphogenesis | 5 | 1.89E−02 | 4.84 |
G2/M transition of mitotic cell cycle | 5 | 1.89E−02 | 4.84 |
Ossification | 8 | 2.45E−02 | 2.79 |
Hippo signaling | 4 | 2.58E−02 | 6.16 |
Positive regulation of cell proliferation | 25 | 3.25E−02 | 1.56 |
Spermatogenesis | 20 | 3.68E−02 | 1.64 |
Keratinocyte differentiation | 7 | 3.75E−02 | 2.82 |
Liver development | 8 | 4.77E−02 | 2.42 |
Female gonad development | 4 | 4.83E−02 | 4.84 |
Microarray analyses were performed on Lats1flox/flox;Lats2 flox/flox granulosa cells infected with Ad-eGFP or Ad-cre for 30 h.